Dr. Axel Eluid Renteria, MD

Dr. Renteria practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Renteria's NPI, 1437931623, was assigned on October 20, 2023. Dr. Renteria graduated from University of Montreal Faculty of Medicine in 2018. Dr. Renteria's California license number on file is A191679.

Dr. Renteria's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Renteria's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Renteria to 1 more hospital, named with a free account. Dr. Renteria's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Renteria practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Renteria's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Renteria has a license on file in California.

Dmand AI lists chronic sinusitis among the conditions Dr. Renteria treats.

CMS data shows 321 Medicare services from Dr. Renteria across 5 procedure codes in 2024, for 210 Medicare patients. Medicare paid $25,738 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 210 Medicare patients who saw Dr. Renteria in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Renteria's median patient age at 49, with 49% women.

In 2024, Dr. Renteria wrote 138 Medicare Part D claims for 72 patients. 99% of them were for generic drugs. CMS names the drug for 85 of them, across 4 drugs with 11 or more claims each, at $1,974 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Renteria for performance year 2024, reported as part of a group.

Dmand AI links 13 papers to Dr. Renteria, published from 2015 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Rhinitis, Sinusitis and Endoscopy. Dr. Renteria has published most often in Int Forum Allergy Rhinol. Dr. Renteria's most frequent co-authors are Anastasios Maniakas, MD, MS, Michael Tzen-Jeh Chang, MD and Lirit Levi, MD.

CMS Open Payments shows 13 general payments to Dr. Renteria from 3 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 59% of the total. Spirair, Inc. paid the most, $1,300.

Dr. Renteria graduated from University of Montreal Faculty of Medicine in 2018.

Dr. Renteria is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.